# Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

> **NCT01757119** · PHASE1 · COMPLETED · sponsor: **Pierre Fabre Medicament** · enrollment: 55 (actual)

## Conditions studied

- Iron Deficiency Anemia

## Interventions

- **DRUG:** Tardyferon 80 mg

## Key facts

- **NCT ID:** NCT01757119
- **Lead sponsor:** Pierre Fabre Medicament
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2014-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01757119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01757119, "Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01757119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*